Schweihofer, V., Bruss, C., Seitz, S., Glehr, G., Hetterich, M., Weber, F., . . . Wege, A. K. (2025). Breast cancer scoring based on a multiplexed profiling of soluble and cell-associated (immune) markers facilitates the prediction of pembrolizumab therapy. Cancer Cell International, 25(1), . https://doi.org/10.1186/s12935-025-03729-7
Chicago-referens (17:e uppl.)Schweihofer, Verena, et al. "Breast Cancer Scoring Based on a Multiplexed Profiling of Soluble and Cell-associated (immune) Markers Facilitates the Prediction of Pembrolizumab Therapy." Cancer Cell International 25, no. 1 (2025). https://doi.org/10.1186/s12935-025-03729-7.
MLA-referens (9:e uppl.)Schweihofer, Verena, et al. "Breast Cancer Scoring Based on a Multiplexed Profiling of Soluble and Cell-associated (immune) Markers Facilitates the Prediction of Pembrolizumab Therapy." Cancer Cell International, vol. 25, no. 1, 2025, https://doi.org/10.1186/s12935-025-03729-7.
